ExodusPoint Capital Management, LP - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 72 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$430
-24.6%
57,934
-3.9%
0.00%
-40.0%
Q1 2023$570
+15.4%
60,277
+30.1%
0.01%
-28.6%
Q4 2022$494
-99.7%
46,347
+160.4%
0.01%
+250.0%
Q3 2021$158,000
+69.9%
17,800
+49.6%
0.00%
+100.0%
Q4 2020$93,00011,9000.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Interchange Capital Partners, LLC 16,420$145,0000.24%
ACT CAPITAL MANAGEMENT, LLC 37,500$332,0000.17%
GSA CAPITAL PARTNERS LLP 68,205$604,0000.06%
GOODWIN DANIEL L 10,000$88,0000.04%
SABBY MANAGEMENT, LLC 26,488$235,0000.03%
EMFO, LLC 1,666$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,166$701,0000.01%
Retirement Group, LLC 1,129$15,0000.01%
Wealthspire Advisors, LLC 14,348$127,0000.00%
BLAIR WILLIAM & CO/IL 82,366$730,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders